ANNEX II附則
ANNEX II Annexes I, III and IIIa to Directive 2004/37/EC are amended as follows: (1) in Annex I, the title is replaced by the following: ‘ List of substances, mixtures and processes (Article 2, points (a)(ii) and (b)(ii)) ’; (2) in Annex III, point A, the row related to inorganic lead and its compounds is replaced by the following: ‘Name of agent EC No ( 1 ) CAS No ( 2 ) Limit values Notation Transitional measures 8 hours ( 3 ) Short-term ( 4 ) mg/m 3 ( 5 ) ppm ( 6 ) f/ml ( 7 ) mg/m 3 ( 5 ) ppm ( 6 ) f/ml ( 7 ) Lead and its inorganic compounds 0,03 ( 8 ) Non-threshold reprotoxic substance (3) Annex IIIa is replaced by the following: ‘ANNEX’ IIIa BIOLOGICAL LIMIT VALUES AND HEALTH SURVEILLANCE MEASURES (Article 16(4)) Lead and its inorganic compounds 1.1. Biological monitoring must include measuring the blood lead level (PbB) using absorption spectrometry or a method giving equivalent results. 1.1.1. Until 31 December 2028, the binding biological limit value is: 30 μg Pb/100 ml blood For workers whose blood lead level exceeds the biological limit value of 30 μg Pb/100 ml blood due to exposure which has occurred before 9 April 2026, but is below 70 μg Pb/100 ml blood, medical surveillance is carried out on a regular basis. If a declining trend towards the limit value of 30 μg Pb/100 ml blood is established in those workers, they may be allowed to continue with work involving exposure to lead. 1.1.2. From 1 January 2029, the binding biological limit value is: 15 μg Pb/100 ml blood ( 9 ) For workers whose blood lead level exceeds the biological limit value of 15 μg Pb/100 ml blood due to exposure which has occurred before 9 April 2026, but is below 30 μg Pb/100 ml blood, medical surveillance is carried out on a regular basis. If a declining trend towards the limit value of 15 μg Pb/100 ml blood is established in those workers, they may be allowed to continue with work involving exposure to lead. 1.2. Medical surveillance is carried out if exposure to a concentration of lead in air is greater than 0,015 mg/m 3 , calculated as a time-weighted average over 40 hours per week, or a blood lead level greater than 9 μg Pb/100 ml blood is measured in individual workers. Medical surveillance is also carried out with regard to female workers of childbearing age whose blood lead level exceeds 4,5 μg Pb/100 ml blood or the national reference value of the general population not occupationally exposed to lead, if such a value exists. . ( 9 ) It is recommended that the blood lead level in women of childbearing age does not exceed the reference values of the general population not occupationally exposed to lead in the respective EU Member State. When national reference levels are not available, it is recommended that blood lead levels in women of childbearing age do not exceed the Biological Guidance Value of 4,5 μg/100 ml." ( 9 ) It is recommended that the blood lead level in women of childbearing age does not exceed the reference values of the general population not occupationally exposed to lead in the respective EU Member State. When national reference levels are not available, it is recommended that blood lead levels in women of childbearing age do not exceed the Biological Guidance Value of 4,5 μg/100 ml.’ ( 1 ) EC No, i.e. Einecs, ELINCS or NLP, is the official number of the substance within the European Union, as defined in Annex VI, Part 1, Section 1.1.1.2, to Regulation (EC) No 1272/2008. ( 2 ) CAS No: Chemical Abstract Service Registry Number. ( 3 ) Measured or calculated in relation to a reference period of 8-hour time-weighted average (TWA). ( 4 ) Short-term exposure limit (STEL). A limit value above which exposure should not occur and which is related to a 15-minute period unless otherwise specified. ( 5 ) mg/m 3 = milligrams per cubic metre of air at 20 °C and 101,3 kPa (760 mm mercury pressure). ( 6 ) ppm = parts per million by volume in air (ml/m 3 ). ( 7 ) f/ml = fibres per millilitre. ( 8 ) Inhalable fraction.’;